About: Mofegiline

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Mofegiline (MDL-72,974) is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B) and semicarbazide-sensitive amine oxidase (SSAO) which was under investigation for the treatment of Parkinson's disease and Alzheimer's disease, but was never marketed.

Property	Value
dbo:abstract	Mofegiline (MDL-72,974) is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B) and semicarbazide-sensitive amine oxidase (SSAO) which was under investigation for the treatment of Parkinson's disease and Alzheimer's disease, but was never marketed. (en)
dbo:casNumber	119386-96-8
dbo:fdaUniiCode	1FMJ6D8Y1B
dbo:pubchem	6437850
dbo:thumbnail	wiki-commons:Special:FilePath/Mofegiline.svg?width=300
dbo:wikiPageID	33869978 (xsd:integer)
dbo:wikiPageLength	4251 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1113758721 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Enzyme_inhibitor dbc:Abandoned_drugs dbc:Monoamine_oxidase_inhibitors dbr:Alzheimer's_disease dbc:Antiparkinsonian_agents dbr:Parkinson's_disease dbr:Ladostigil dbr:Lazabemide dbr:Binding_selectivity dbr:Rasagiline dbc:Antidementia_agents dbr:Selegiline dbr:Semicarbazide-sensitive_amine_oxidase dbr:Monoamine_oxidase_B
dbp:atcPrefix	None (en)
dbp:c	11 (xsd:integer)
dbp:casNumber	119386 (xsd:integer)
dbp:chemspiderid	4942371 (xsd:integer)
dbp:eliminationHalfLife	-10800.0
dbp:excretion	Urine (en)
dbp:f	2 (xsd:integer)
dbp:h	13 (xsd:integer)
dbp:iupacName	-2 (xsd:integer)
dbp:legalStatus	Development terminated (en)
dbp:n	1 (xsd:integer)
dbp:pubchem	6437850 (xsd:integer)
dbp:routesOfAdministration	Oral (en)
dbp:smiles	Fc1cccCCCCN (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	VXLBSYHAEKDUSU-JXMROGBWSA-N (en)
dbp:synonyms	MDL-72,974A (en)
dbp:unii	1 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Antioxidants dbt:Drugbox dbt:Reflist dbt:Antiparkinson dbt:Monoamine_metabolism_modulators dbt:Antidementia
dcterms:subject	dbc:Abandoned_drugs dbc:Monoamine_oxidase_inhibitors dbc:Antiparkinsonian_agents dbc:Antidementia_agents
gold:hypernym	dbr:Inhibitor
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatAntidementiaAgents yago:WikicatAntiparkinsonianAgents yago:WikicatMonoamineOxidaseInhibitors yago:Agent109190918 yago:Agent114778436 yago:Antidepressant102718811 yago:CausalAgent100007347 yago:Drug103247620 yago:Matter100020827 yago:Medicine103740161 yago:MonoamineOxidaseInhibitor103783017 yago:PhysicalEntity100001930 dbo:Drug yago:Substance100020090
rdfs:comment	Mofegiline (MDL-72,974) is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B) and semicarbazide-sensitive amine oxidase (SSAO) which was under investigation for the treatment of Parkinson's disease and Alzheimer's disease, but was never marketed. (en)
rdfs:label	Mofegiline (en)
owl:sameAs	freebase:Mofegiline yago-res:Mofegiline wikidata:Mofegiline dbpedia-sh:Mofegiline dbpedia-sr:Mofegiline https://global.dbpedia.org/id/YR19
prov:wasDerivedFrom	wikipedia-en:Mofegiline?oldid=1113758721&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Mofegiline.svg
foaf:isPrimaryTopicOf	wikipedia-en:Mofegiline
is dbo:wikiPageWikiLink of	dbr:List_of_adrenergic_drugs dbr:List_of_dopaminergic_drugs dbr:Ladostigil dbr:List_of_drugs:_Mo
is foaf:primaryTopic of	wikipedia-en:Mofegiline